HomeTagsNeurological

neurological

Biotechnology

Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients

News Desk - August 1, 2023

The company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in children...

Biotechnology

Terran Biosciences announces publication of PCT patent application covering novel orally active forms of psilocin with improved pharmacokinetic properties

PR Newswire - February 27, 2023

Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has announced the publication of...

Biotechnology

Terran Biosciences announces publication of PCT patent applications covering orally active forms of DMT and 5-MeO-DMT and long-acting MDMA

PR Newswire - February 6, 2023

Terran Biosciences, a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has announced the publication of PCT...

Biotechnology

Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia

PR Newswire - February 6, 2023

Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, announced that the U.S. Food and Drug Administration (FDA) has...

Biotechnology

Neuron23 and QIAGEN Announce Collaboration to Develop the Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

PR Newswire - September 15, 2022

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN ( NYSE: QGEN;...

12 Page 1 of 2